drugset / Trial / NCT00169728

Vaccination of Children Following Allogeneic Stem Cell Transplantation

NCT00169728

Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine the immunogenicity and tolerability of the DTaP-IPV-HBV/Hib combination vaccine Infanrix hexa and the heptavalent pneumococcal conjugate vaccine Prevenar in pediatric recipients of allogeneic haematopoietic stem cell transplantation.

Timeline

Start
2003-09
Primary completion
2006-06
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Infanrix hexa Vaccine
Subject Prevnar 13 Vaccine